ArticleCPT: pharmacometrics & systems pharmacology2026
Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation.
Amitava Mitra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.